 do a better job in keeping the current transplanted organs functioning well for a long period of time and having those patients feel better, have safer drugs with better quality of life. And there are therapies that are currently in development to try to improve the outcomes that are clearly safer and could have better tolerability to the patients. But they're in early stages of what we call phase one and two of development.